163 related articles for article (PubMed ID: 25966742)
1. Ginsenoside rh2 inhibits cancer stem-like cells in skin squamous cell carcinoma.
Liu S; Chen M; Li P; Wu Y; Chang C; Qiu Y; Cao L; Liu Z; Jia C
Cell Physiol Biochem; 2015; 36(2):499-508. PubMed ID: 25966742
[TBL] [Abstract][Full Text] [Related]
2. Ginsenoside Rh2 inhibits hepatocellular carcinoma through β-catenin and autophagy.
Yang Z; Zhao T; Liu H; Zhang L
Sci Rep; 2016 Jan; 6():19383. PubMed ID: 26783250
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of autophagy potentiates anticancer property of 20(S)-ginsenoside Rh2 by promoting mitochondria-dependent apoptosis in human acute lymphoblastic leukaemia cells.
Xia T; Wang J; Wang Y; Wang Y; Cai J; Wang M; Chen Q; Song J; Yu Z; Huang W; Fang J
Oncotarget; 2016 May; 7(19):27336-49. PubMed ID: 27027340
[TBL] [Abstract][Full Text] [Related]
4. Ginsenoside Rh2 Mitigates Pediatric Leukemia Through Suppression of Bcl-2 in Leukemia Cells.
Wang X; Wang Y
Cell Physiol Biochem; 2015; 37(2):641-50. PubMed ID: 26344648
[TBL] [Abstract][Full Text] [Related]
5. Ginsenoside Rh2 inhibits prostate cancer cell growth through suppression of microRNA-4295 that activates CDKN1A.
Gao Q; Zheng J
Cell Prolif; 2018 Jun; 51(3):e12438. PubMed ID: 29457293
[TBL] [Abstract][Full Text] [Related]
6. Ginsenoside 20(S)-Rh2 exerts anti-cancer activity through the Akt/GSK3β signaling pathway in human cervical cancer cells.
Shi X; Yang J; Wei G
Mol Med Rep; 2018 Mar; 17(3):4811-4816. PubMed ID: 29363731
[TBL] [Abstract][Full Text] [Related]
7. 20S-Ginsenoside Rh2 induces apoptosis in human Leukaemia Reh cells through mitochondrial signaling pathways.
Xia T; Wang JC; Xu W; Xu LH; Lao CH; Ye QX; Fang JP
Biol Pharm Bull; 2014; 37(2):248-54. PubMed ID: 24492721
[TBL] [Abstract][Full Text] [Related]
8. Lgr5-positive cells are cancer stem cells in skin squamous cell carcinoma.
Liu S; Gong Z; Chen M; Liu B; Bian D; Wu K
Tumour Biol; 2014 Nov; 35(11):11605-12. PubMed ID: 25135431
[TBL] [Abstract][Full Text] [Related]
9. Ginsenoside Rh2 inhibits human A172 glioma cell proliferation and induces cell cycle arrest status via modulating Akt signaling pathway.
Li KF; Kang CM; Yin XF; Li HX; Chen ZY; Li Y; Zhang Q; Qiu YR
Mol Med Rep; 2018 Feb; 17(2):3062-3068. PubMed ID: 29207171
[TBL] [Abstract][Full Text] [Related]
10. 20(S)-ginsenoside Rh2 inhibits the proliferation and induces the apoptosis of KG-1a cells through the Wnt/β-catenin signaling pathway.
Chen Y; Liu ZH; Xia J; Li XP; Li KQ; Xiong W; Li J; Chen DL
Oncol Rep; 2016 Jul; 36(1):137-46. PubMed ID: 27121661
[TBL] [Abstract][Full Text] [Related]
11.
Chen H; Wang X; Chen Y; Han J; Kong D; Zhu M; Fu X; Wu Y
Theranostics; 2019; 9(26):8321-8331. PubMed ID: 31754399
[TBL] [Abstract][Full Text] [Related]
12. Overexpression of PER3 Inhibits Self-Renewal Capability and Chemoresistance of Colorectal Cancer Stem-Like Cells via Inhibition of Notch and β-Catenin Signaling.
Zhang F; Sun H; Zhang S; Yang X; Zhang G; Su T
Oncol Res; 2017 May; 25(5):709-719. PubMed ID: 27983919
[TBL] [Abstract][Full Text] [Related]
13. Grape compounds suppress colon cancer stem cells in vitro and in a rodent model of colon carcinogenesis.
Reddivari L; Charepalli V; Radhakrishnan S; Vadde R; Elias RJ; Lambert JD; Vanamala JK
BMC Complement Altern Med; 2016 Aug; 16():278. PubMed ID: 27506388
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of prostatic cancer growth by ginsenoside Rh2.
Zhang Q; Hong B; Wu S; Niu T
Tumour Biol; 2015 Apr; 36(4):2377-81. PubMed ID: 25416441
[TBL] [Abstract][Full Text] [Related]
15. WM130 preferentially inhibits hepatic cancer stem-like cells by suppressing AKT/GSK3β/β-catenin signaling pathway.
Ni CX; Qi Y; Zhang J; Liu Y; Xu WH; Xu J; Hu HG; Wu QY; Wang Y; Zhang JP
Oncotarget; 2016 Nov; 7(48):79544-79556. PubMed ID: 27783993
[TBL] [Abstract][Full Text] [Related]
16. Ginsenoside-Rb1 targets chemotherapy-resistant ovarian cancer stem cells via simultaneous inhibition of Wnt/β-catenin signaling and epithelial-to-mesenchymal transition.
Deng S; Wong CKC; Lai HC; Wong AST
Oncotarget; 2017 Apr; 8(16):25897-25914. PubMed ID: 27825116
[TBL] [Abstract][Full Text] [Related]
17. Quercetin inhibit human SW480 colon cancer growth in association with inhibition of cyclin D1 and survivin expression through Wnt/beta-catenin signaling pathway.
Shan BE; Wang MX; Li RQ
Cancer Invest; 2009 Jul; 27(6):604-12. PubMed ID: 19440933
[TBL] [Abstract][Full Text] [Related]
18. Ginsenoside Rh2 and Rg3 inhibit cell proliferation and induce apoptosis by increasing mitochondrial reactive oxygen species in human leukemia Jurkat cells.
Xia T; Wang YN; Zhou CX; Wu LM; Liu Y; Zeng QH; Zhang XL; Yao JH; Wang M; Fang JP
Mol Med Rep; 2017 Jun; 15(6):3591-3598. PubMed ID: 28440403
[TBL] [Abstract][Full Text] [Related]
19. LGR5 promotes cancer stem cell traits and chemoresistance in cervical cancer.
Cao HZ; Liu XF; Yang WT; Chen Q; Zheng PS
Cell Death Dis; 2017 Sep; 8(9):e3039. PubMed ID: 28880275
[TBL] [Abstract][Full Text] [Related]
20. Aryl hydrocarbon receptor/cytochrome P450 1A1 pathway mediates breast cancer stem cells expansion through PTEN inhibition and β-Catenin and Akt activation.
Al-Dhfyan A; Alhoshani A; Korashy HM
Mol Cancer; 2017 Jan; 16(1):14. PubMed ID: 28103884
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
